Form 4: DaVita Inc. CFO Joel Ackerman Reports Stock Transactions
SEC Form 4 Filing
CFO and Treasurer of DaVita Inc., Joel Ackerman, reports acquisition and disposal of company stock due to vesting of performance stock units and tax obligations.
Summary
- On March 14, 2024, Joel Ackerman, CFO and Treasurer of DaVita Inc., acquired 14,349 shares of common stock related to performance stock units that vested on March 15, 2024.
- Ackerman also acquired 1,445 shares of common stock related to performance stock units that vested on March 15, 2024.
- On March 15, 2024, Ackerman acquired 10,977 restricted stock units scheduled to vest in the future.
- Also on March 15, 2024, 8,064 shares were withheld to cover tax obligations at a price of $136 per share.
- Following these transactions, Ackerman beneficially owns 175,510 shares of DaVita Inc. common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transactions are routine and related to compensation. The vesting of performance stock units is a positive sign, but the tax-related sale is a minor negative.
Positives
- The vesting of performance stock units indicates that performance criteria were met, which could be seen as a positive signal.
Negatives
- The disposal of 8,064 shares to cover tax obligations, while routine, represents a decrease in Ackerman's holdings.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's future prospects.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in the healthcare industry, with companies like UnitedHealth Group (UNH) and CVS Health (CVS) also subject to similar reporting requirements.
- The vesting of performance stock units is a typical form of executive compensation, aligning management's interests with those of shareholders, similar to practices at companies like Fresenius Medical Care (FMS).
Stakeholder Impact
- The transactions have a minor impact on shareholders by slightly diluting the stock due to the issuance of new shares for vested units.
- The tax-related sale has a minor impact on shareholders by slightly increasing the stock available.
Key Dates
| Date | Description |
|---|---|
| 03/15/2020 | Date of grant of performance stock units, 100% of which vested on March 15, 2024. |
| 03/15/2021 | Date of grant of performance stock units, 100% of which vested on March 15, 2024. |
| 03/14/2024 | Acquisition of 14,349 shares of common stock due to vesting of performance stock units. |
| 03/14/2024 | Acquisition of 1,445 shares of common stock due to vesting of performance stock units. |
| 03/15/2024 | Acquisition of 10,977 restricted stock units. |
| 03/15/2024 | Disposal of 8,064 shares for tax withholding. |
| 03/15/2027 | 50% vesting date for restricted stock units. |
| 03/15/2028 | 50% vesting date for restricted stock units. |
| 03/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.